Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

被引：0
|
作者：
Mushtaq, Adeela
Latif, Azka
Kapoor, Vikas
Warraich, Faiza Hassan
Warraich, Sami Ullah
Iftikhar, Ahmad
Tenneti, Pavan
Zafar, Raahem Nayab
Russ, Atlantis Dawn
Abraham, Ivo
McBride, Ali
Anwer, Faiz
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5413
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of Elotuzumab Based Combinations in Patients with Multiple Myeloma - a Systematic Review
    Farooqui, Arafat Ali
    Anjum, Ahmad
    Farooqi, Muhammad Saad
    Bin Farooq, Talha
    Shaukat, Tanveer
    Ashraf, Aqsa
    Sarfraz, Humaira
    Shah, Zunairah
    Tariq, Muhammad Junaid
    Anwer, Faiz
    BLOOD, 2019, 134
  • [32] Carfilzomib/pomalidomideLack of efficacy in multiple myeloma: case report
    Reactions Weekly, 2021, 1871 (1) : 114 - 114
  • [33] Daratumumab-Based Regimens with Prior Carfilzomib in Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Tungesvik, Alexandre
    Huang, Jessica
    Sudalagunta, Praneeth
    Dimaggio, Elizabeth
    De Avila, Gabe
    Tandon, Ankita
    Nelson, Rebeccah
    Olson, Laura
    Tobon, Katherine
    Shain, Kenneth
    Brayer, Jason
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S327 - S328
  • [34] An overview of the role of carfilzomib in the treatment of multiple myeloma
    Ziogas, Dimitrios C.
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (17) : 1883 - 1897
  • [35] The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: A systematic review
    Roellig, Christoph
    Illmer, Thomas
    CANCER TREATMENT REVIEWS, 2009, 35 (05) : 425 - 430
  • [36] Efficacy and Safety of Selinexor for Heavily Pretreated Multiple Myeloma Treatment - A Systematic Review
    Tariq, Muhammad Junaid
    Farooqui, Arafat
    Faisal, Muhammad Salman
    Farooqi, Muhammad
    Shaukat, Tanveer
    Anjum, Ahmad
    Rehman, Saifur
    Ullah, Muhammad Qudrat
    Bajwa, Hamza
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E121 - E121
  • [37] Optimizing carfilzomib use in multiple myeloma treatment
    Yoon, Sung-Soo
    BLOOD RESEARCH, 2019, 54 (03) : 159 - 161
  • [38] DESCRIPTIVE ANALYSIS OF THE CARFILZOMIB TOXICITY PROFILE IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE IN A THIRD LEVEL CENTER
    Gutierrez Lopez de Ocariz, X.
    Cuellar Perez-Avila, C.
    Zamanillo Herreros, I
    Iniguez Garcia, R.
    Poza Santaella, M.
    Alonso Fernandez, R.
    Sanchez Pina, J. M.
    Gonzalez Medina, J.
    Buenaventura Buendia, B.
    De Nicolas Sol, R.
    Vera Guerrero, E.
    Hidalgo Soto, M.
    Lopez Munoz, N.
    Lahuerta Palacios, J. J.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2019, 104 : 201 - 202
  • [39] Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis
    LeBlanc, Richard
    Mian, Hira
    Reece, Donna
    Su, Jiandong
    Masih-Khan, Esther
    Chu, Michael
    Jimenez-Zepeda, Victor
    Sebag, Michael
    Song, Kevin
    Louzada, Martha
    Kotb, Rami
    Visram, Alissa
    White, Darrell
    Stakiw, Julie
    Reiman, Antony
    Aslam, Muhammad
    Bergstrom, Debra
    Kaedbey, Rayan
    Gul, Engin
    Venner, Christopher
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (05) : 815 - 823
  • [40] Efficacy of Bortezomib Based Regimens and Disease Monitoring in Light Chain Multiple Myeloma: A Review of Literature
    Malik, Mustafa Nadeem
    Rafae, Abdul
    Aslam, Shehroz
    Riaz, Rida
    Durer, Seren
    Durer, Ceren
    Abu Zar, Muhammad
    Shah, Zunairah
    Kamal, Ahmad
    Qureshi, Anum
    Jose, Jemin Aby
    Selene, Insija Ilyas
    Jamil, Faiza
    Shafqat, Madeeha
    Anwer, Faiz
    BLOOD, 2018, 132
12345